CN102174501B - Preparation method of three-dimensional histioid cardiac muscular tissue for studying simulated microgravity effect - Google Patents
Preparation method of three-dimensional histioid cardiac muscular tissue for studying simulated microgravity effect Download PDFInfo
- Publication number
- CN102174501B CN102174501B CN 201110061542 CN201110061542A CN102174501B CN 102174501 B CN102174501 B CN 102174501B CN 201110061542 CN201110061542 CN 201110061542 CN 201110061542 A CN201110061542 A CN 201110061542A CN 102174501 B CN102174501 B CN 102174501B
- Authority
- CN
- China
- Prior art keywords
- cardiac muscular
- muscular tissue
- mass concentration
- preparation
- dimensional
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention relates to a preparation method of a three-dimensional histioid cardiac muscular tissue for studying a simulated microgravity effect, in particular relating to a preparation method of a three-dimensional histioid cardiac muscular tissue microballoon, aiming at solving the problems that according to the current cell three-dimensional culture method for studying the simulated microgravity effect, the cytodex microcarrier material is toxic and is not conducive to generation of cardiocytes, a great number of cells are needed for culture, cell harvesting is difficult, the cells are prone to interference of shearing force when being cultured in a klinostat and the continual contraction time of the cardiocytes is short. The method comprises the following steps: preparing a mixed solution; preparing cardiocytes; preparing a cell suspension, adding the cell suspension to a divalent positive ion solution to obtain microballoons; culturing the mircoballons in a culture medium to form the three-dimensional histioid cardiac muscular tissue. The three-dimensional histioid cardiac muscular tissue prepared by the method prepared by the invention can be cultured on a long-term basis, needs no passage and can maintain contraction of the cardiac muscular tissue for a long time. The method is applied to the research fields of space biology, aerospace medicine and tissue engineering.
Description
Technical field
The present invention relates to a kind of preparation method of three-dimensional type cardiac muscular tissue.
Background technology
Outer space environment has characteristics such as microgravity, very low temperature, high vacuum and severe radiation, and wherein, microgravity has a significant effect to human body physiological function.The aerospace medicine investigator has carried out medical observation and the research of a large amount of microgravitys to the function of human body influence both at home and abroad; Find that long-time space flight can cause that pathological change to a certain degree appears in physiological function, comprises that mainly the pathologic of cardiovascular systems, musculature, immunity system and Skeletal system changes.Because cardiovascular systems is being kept the normal activities of human body; Therefore study the influence of microgravity to cardiovascular system of human body; Inquire into its mechanism and formulate effective safeguard procedures, for guaranteeing that the health of spacefarer when the space flight is with effectively work is significant.
Myocardial cell's model of research microgravity effect mainly is through culturing cell in gyrator at present, thereby reaches the deterministic simulation microgravity environment.Myocardial cell's three-dimensional culture method is to be used to study simulated microgravity effect cell culture processes the most widely at present, makes the myocardial cell be grown in the surface of cytodex microcarrier.There are many deficiencies in this method: (1) cytodex microcarrier material has toxicity, can have a negative impact by pair cell; The cell concentration that needs when (2) cultivating is big, collects the cell difficulty; When (3) in gyrator, cultivating, be subject to the interference of the shearing force of factor generations such as bubble; (4) myocardial cell's lasting ST is short.
Summary of the invention
The present invention will solve the cell three-dimensional culture method cytodex microcarrier material that is used for studying the simulated microgravity effect at present to have toxicity and the myocardial cell is had a negative impact; The cell concentration that needs during cultivation is big; Collect the cell difficulty; Cell is subject to the interference of shearing force when in gyrator, cultivating, the problem that myocardial cell's lasting ST is short provides a kind of preparation method who is used to study three-dimensional type of cardiac muscular tissue's microballoon of simulated microgravity effect.
A kind of preparation method who is used to study the three-dimensional type cardiac muscular tissue of simulated microgravity effect of the present invention; Carry out according to the following steps: be 0.05%～3% sodium alginate soln with mass concentration one, be that 10%～50% type i collagen protein solution mixes, obtain mixing solutions mass concentration; Two, will the be born Wistar rat suckling mouse heart of back 1～3d places the PBS solution of 0～4 ℃ 0.1mol/L, with the PBS solution cleaning heart of 0～4 ℃ 0.1mol/L 3～5 times, again heart tissue is cut into 1～3mm then
3The tissue block of size, the PBS solution with 0～4 ℃ 0.1mol/L cleans 3～5 times again, then tissue block is digested 10～30min with Digestive system; The DMEM substratum that adds 10 times of volumes of tissue block again; Abandon supernatant after centrifugal, in deposition, add the DMEM substratum then and process cell suspension A, cell suspension A is inoculated in the culturing bottle; Adherent 90～the 120min of differential obtains the myocardial cell of purifying; Three, the myocardial cell with purifying mixes with the mixing solutions that step 1 makes, and processing cell density is 0.5 * 10
6～5 * 10
6Myocardial cell's suspension of individual/mL adopts syringe needle that myocardial cell's suspension is dropwise joined in the positive solion of divalence of 25～100mmol/L, leaves standstill 5～20min, obtains wrapping up myocardial cell's microballoon; It is after leaving standstill 5～20min in 0.1%～3% the sodium alginate soln that the microballoon that four, will wrap up the myocardial cell adds mass concentration; Put into mass concentration again and be 0.5～2% Poly-L-Lysine Solution and leave standstill 5～20min; The microballoon that will pass through the parcel myocardial cell of leaving standstill then is put in the DMEM substratum and carries out 1～2 week of dimensional culture, promptly forms the three-dimensional type cardiac muscular tissue with the function that continues to beat; Wherein the quality of type i collagen protein solution is 0.1%～50% of a sodium alginate soln quality in the step 1; Digestive system is made up of pancreatin and collagenase II in the step 2, and the mass concentration of pancreatin is 0.02～0.2% in the Digestive system, and the mass concentration of collagenase II is 0.01～0.1%; The volume of Digestive system is 9～12 times of tissue block volume in the step 2; All contain mass concentration in the DMEM substratum in step 2 and the step 4 and be 10%～15% foetal calf serum; The cell density of cell suspension A in the step 2 is 0.5 * 10
6～5 * 10
6Individual/mL; Divalent cation is calcium ion, barium ion or strontium ion in the divalent cation solution in the step 3; The volume of sodium alginate soln is 9～12 times of microsphere volume in the step 4, and the volume of Poly-L-Lysine Solution is 9～12 times of microsphere volume.
The present invention adopts tissue engineering technique to have the class cardiac muscular tissue of myocardial structural and function in external structure; Such cardiac muscular tissue has the characteristics very close with real heart tissue and is convenient to accuracy controlling; Utilize such class cardiac muscular tissue to replace the myocardial cell to be used to study myocardial structural and the The Molecular Biology Mechanism of changing function simulated weightlessness conditions under, build one and be applicable to that space life science is studied and the three-dimension cardiac muscle cell cultures platform of space environment risk assessment.
Method of the present invention has the following advantages:
1, myocardial cell's less shearing force that receives in microballoon is disturbed;
2, the myocardial cell forms globoferous cell group in microballoon, on biology performance with more approaching in body tissue;
3, microballoon has certain porosity, and the myocardial cell can accept nutritive substance and can metabolic waste be discharged again in microballoon;
4, but myocardial cell's long-term cultivation in microballoon need not to go down to posterity, and is more suitable for the space and carries;
5, use the three-dimensional type cardiac muscular tissue of the inventive method preparation can keep myocardial cell's contractile function for a long time, the time length is 6 months; And the lasting ST of present two-dimentional cultural method myocardial cell is 130 days, and it is 2 months that present three-dimensional culture method myocardial cell continues ST.
Description of drawings
Fig. 1 is the photo of the parcel myocardial cell's that step 3 obtains in the embodiment 24 microballoon; Fig. 2 amplifies 40 times photo for the parcel myocardial cell's that step 3 in the embodiment 24 obtains microballoon at microscopically; Fig. 3 is that the microballoon after DAPI dyeing amplifies 40 times photo in the embodiment 24 at microscopically; Fig. 4 is the photo of the microballoon of the three-dimensional type cardiac muscular tissue of 2 months parcel of cultivation in the embodiment 24; Fig. 5 is that the microballoon of cultivating 2 months the three-dimensional type cardiac muscular tissue of parcel in the embodiment 24 amplifies 400 times photo at microscopically; Fig. 6 is that 500 times stereoscan photograph amplifies in the three-dimensional type cardiac muscular tissue of cultivating in the embodiment 24 2 months; Fig. 7 is that 4000 times stereoscan photograph amplifies in the three-dimensional type cardiac muscular tissue of cultivating in the embodiment 24 2 months; Fig. 8 for three-dimensional type cardiac muscular tissue in the embodiment 24 at the beat detection figure of frequency of different culture time lock.
Embodiment
Technical scheme of the present invention is not limited to following cited embodiment, also comprises the arbitrary combination between each embodiment.
Embodiment one: this embodiment is a kind of to be used to study the preparation method of the three-dimensional type cardiac muscular tissue of simulated microgravity effect; Carry out according to the following steps: be 0.05%～3% sodium alginate soln with mass concentration one, be that 10%～50% type i collagen protein solution mixes, obtain mixing solutions mass concentration; Two, will the be born Wistar rat suckling mouse heart of back 1～3d places the PBS solution of 0～4 ℃ 0.1mol/L, with the PBS solution cleaning heart of 0～4 ℃ 0.1mol/L 3～5 times, again heart tissue is cut into 1～3mm then
3The tissue block of size, the PBS solution with 0～4 ℃ 0.1mol/L cleans 3～5 times again, then tissue block is digested 10～30min with Digestive system; The DMEM substratum that adds 10 times of volumes of tissue block again; Abandon supernatant after centrifugal, in deposition, add the DMEM substratum then and process cell suspension A, cell suspension A is inoculated in the culturing bottle; Adherent 90～the 120min of differential obtains the myocardial cell of purifying; Three, the myocardial cell with purifying mixes with the mixing solutions that step 1 makes, and processing cell density is 0.5 * 10
6～5 * 10
6Myocardial cell's suspension of individual/mL adopts syringe needle that myocardial cell's suspension is dropwise joined in the positive solion of divalence of 25～100mmol/L, leaves standstill 5～20min, obtains wrapping up myocardial cell's microballoon; It is after leaving standstill 5～20min in 0.1%～3% the sodium alginate soln that the microballoon that four, will wrap up the myocardial cell adds mass concentration; Put into mass concentration again and be 0.5～2% Poly-L-Lysine Solution and leave standstill 5～20min; The microballoon that will pass through the parcel myocardial cell of leaving standstill then is put in the DMEM substratum and carries out 1～2 week of dimensional culture, promptly forms the three-dimensional type cardiac muscular tissue with the function that continues to beat; Wherein the quality of type i collagen protein solution is 0.1%～50% of a sodium alginate soln quality in the step 1; Digestive system is made up of pancreatin and collagenase II in the step 2, and the mass concentration of pancreatin is 0.02～0.2% in the Digestive system, and the mass concentration of collagenase II is 0.01～0.1%; The volume of Digestive system is 9～12 times of tissue block volume in the step 2; All contain mass concentration in the DMEM substratum in step 2 and the step 4 and be 10%～15% foetal calf serum; The cell density of cell suspension A in the step 2 is 0.5 * 10
6～5 * 10
6Individual/mL; Divalent cation is calcium ion, barium ion or strontium ion in the divalent cation solution in the step 3; The volume of sodium alginate soln is 9～12 times of microsphere volume in the step 4, and the volume of Poly-L-Lysine Solution is 9～12 times of microsphere volume.
Type i collagen albumen in this embodiment step 1 is rat type i collagen albumen, for purchase obtains.
The method of this embodiment has the following advantages: myocardial cell's less shearing force that receives in microballoon is disturbed; The myocardial cell forms globoferous cell group in microballoon, on biology performance with more approaching in body tissue; Microballoon has certain porosity, and the myocardial cell can accept nutritive substance and can metabolic waste be discharged again in microballoon; But the myocardial cell is long-term cultivation in microballoon, need not to go down to posterity, and is more suitable for the space and carries; Use the three-dimensional type cardiac muscular tissue of the inventive method preparation can keep myocardial cell's contractile function for a long time, the time length is 6 months; And the lasting ST of present two-dimentional cultural method myocardial cell is 130 days, and it is 2 months that present three-dimensional culture method myocardial cell continues ST.
Embodiment two: what this embodiment and embodiment one were different is: the mass concentration of sodium alginate soln is 0.5%～2% in the step 1.Other is identical with embodiment one.
Embodiment three: what this embodiment was different with embodiment one or two is: the mass concentration of sodium alginate soln is 1% in the step 1.Other is identical with embodiment one or two.
Embodiment four: what this embodiment was different with one of embodiment one to three is: the mass concentration of type i collagen protein solution is 20%～40% in the step 1.Other is identical with one of embodiment one to three.
Embodiment five: what this embodiment was different with one of embodiment one to three is: the mass concentration of type i collagen protein solution is 30% in the step 1.Other is identical with one of embodiment one to three.
Embodiment six: what this embodiment was different with one of embodiment one to five is: the quality of type i collagen protein solution is 5%～40% of a sodium alginate soln quality in the step 1.Other is identical with one of embodiment one to five.
Embodiment seven: what this embodiment was different with one of embodiment one to five is: the quality of type i collagen protein solution is 10%～30% of a sodium alginate soln quality in the step 1.Other is identical with one of embodiment one to five.
Embodiment eight: what this embodiment was different with one of embodiment one to five is: the quality of type i collagen protein solution is 20% of a sodium alginate soln quality in the step 1.Other is identical with one of embodiment one to five.
Embodiment nine: what this embodiment was different with one of embodiment one to eight is: the mass concentration of pancreatin is 0.05～0.15% in the Digestive system of step 2.Other is identical with one of embodiment one to eight.
Embodiment ten: what this embodiment was different with one of embodiment one to eight is: the mass concentration of pancreatin is 0.1% in the Digestive system of step 2.Other is identical with one of embodiment one to eight.
Embodiment 11: what this embodiment was different with one of embodiment one to ten is: the mass concentration of collagenase II is 0.05% in the Digestive system of step 2.Other is identical with one of embodiment one to ten.
Embodiment 12: what this embodiment was different with one of embodiment one to 11 is: the volume of Digestive system is 10 times of tissue block volume in the step 2.Other is identical with one of embodiment one to 11.
Embodiment 13: what this embodiment was different with one of embodiment one to 12 is: in the step 2 tissue block is digested 20min with Digestive system.Other is identical with one of embodiment one to 12.
Embodiment 14: what this embodiment was different with one of embodiment one to 13 is: the adherent 100min of differential in the step 2.Other is identical with one of embodiment one to 13.
Embodiment 15: what this embodiment was different with one of embodiment one to 14 is: the cell density of the cell suspension A in the step 2 is 1 * 10
6～3 * 10
6Individual/mL.Other is identical with one of embodiment one to 14.
Embodiment 16: what this embodiment was different with one of embodiment one to 14 is: the cell density of the cell suspension A in the step 2 is 2 * 10
6Individual/mL.Other is identical with one of embodiment one to 14.
Embodiment 17: what this embodiment was different with one of embodiment one to 16 is: processing cell density in the step 3 is 1 * 10
6～3 * 10
6Myocardial cell's suspension of individual/mL.Other is identical with one of embodiment one to 16.
Embodiment 18: what this embodiment was different with one of embodiment one to 16 is: processing cell density in the step 3 is 2 * 10
6Myocardial cell's suspension of individual/mL.Other is identical with one of embodiment one to 16.
Embodiment 19: what this embodiment was different with one of embodiment one to 18 is: in the step 3 myocardial cell's suspension is dropwise joined in the positive solion of divalence of 40～80mmol/L.Other is identical with one of embodiment one to 18.
Embodiment 20: what this embodiment was different with one of embodiment one to 18 is: in the step 3 myocardial cell's suspension is dropwise joined in the positive solion of divalence of 60mmol/L.Other is identical with one of embodiment one to 18.
Embodiment 21: what this embodiment was different with one of embodiment one to 20 is: the mass concentration of sodium alginate soln is 0.5%～2% in the step 4.Other is identical with one of embodiment one to 20.
Embodiment 22: what this embodiment was different with one of embodiment one to 20 is: the mass concentration of sodium alginate soln is 1% in the step 4.Other is identical with one of embodiment one to 20.
Embodiment 23: what this embodiment was different with one of embodiment one to 22 is: the mass concentration of Poly-L-Lysine Solution is 1% in the step 4.Other is identical with one of embodiment one to 22.
Embodiment 24: this embodiment is a kind of to be used to study the preparation method of the three-dimensional type cardiac muscular tissue of simulated microgravity effect; Carry out according to the following steps: be 2% sodium alginate soln with mass concentration one, be that 30% type i collagen protein solution mixes, obtain mixing solutions mass concentration; Two, will the be born Wistar rat suckling mouse heart of back 3d places the PBS solution of 4 ℃ 0.1mol/L, with the PBS solution cleaning heart of 4 ℃ 0.1mol/L 5 times, again heart tissue is cut into 1～3mm then
3The tissue block of size with the PBS solution cleaning of 4 ℃ 0.1mol/L 3 times, digests 30min with tissue block with Digestive system more then; The DMEM substratum that adds 10 times of volumes of tissue block again; Abandon supernatant after centrifugal, in deposition, add the DMEM substratum then and process cell suspension A, cell suspension A is inoculated in the culturing bottle; The adherent 120min of differential obtains the myocardial cell of purifying; Three, the myocardial cell with purifying mixes with the mixing solutions that step 1 makes, and processing cell density is 2 * 10
6Myocardial cell's suspension of individual/mL adopts syringe needle that myocardial cell's suspension is dropwise joined in the positive solion of divalence of 100mmol/L, leaves standstill 5min, obtains wrapping up myocardial cell's microballoon; It is after leaving standstill 10min in 1% the sodium alginate soln that the microballoon that four, will wrap up the myocardial cell adds mass concentration; The Poly-L-Lysine Solution of putting into mass concentration 0.5% again leaves standstill 10min; The microballoon that will pass through the parcel myocardial cell of leaving standstill is put in the DMEM substratum and carries out 2 weeks of dimensional culture, promptly forms the three-dimensional type cardiac muscular tissue with the function that continues to beat; Wherein the quality of type i collagen protein solution is 20% of a sodium alginate soln quality in the step 1; Digestive system is made up of pancreatin and collagenase II in the step 2, and the mass concentration of pancreatin is 0.02% in the Digestive system, and the mass concentration of collagenase II is 0.01%; The volume of Digestive system is 10 times of tissue block volume in the step 2; All contain mass concentration in the DMEM substratum in step 2 and the step 4 and be 15% foetal calf serum; The cell density of cell suspension A in the step 2 is 2 * 10
6Individual/mL; Divalent cation is calcium ion, barium ion or strontium ion in the divalent cation solution in the step 3; The volume of sodium alginate soln is 10 times of microsphere volume in the step 4, and the volume of Poly-L-Lysine Solution is 10 times of microsphere volume.
The parcel myocardial cell's that this embodiment step 3 makes microballoon is as illustrated in fig. 1 and 2, and Fig. 1 is the photo of parcel myocardial cell's microballoon, and Fig. 2 is that microballoon amplifies 40 times photo at microscopically, can find out that the size of microballoon is even, and diameter is about 2.3mm.Microballoon is carried out DAPI dyeing, and as shown in Figure 3, Fig. 3 is that the microballoon after DAPI dyeing amplifies 40 times photo at microscopically, can see that the myocardial cell is evenly distributed in microballoon.
The three-dimensional type cardiac muscular tissue of this enforcement preparation is continued to be cultured to 2 months; Form macroscopic three-dimensional type cardiac muscular tissue; Like Fig. 4 and shown in Figure 5; Fig. 4 is the photo of the microballoon of the three-dimensional type cardiac muscular tissue of 2 months parcel of cultivation, and Fig. 5 amplifies 400 times photo for the microballoon of cultivating 2 months parcel three-dimensional type cardiac muscular tissue at microscopically.
A three-dimensional type cardiac muscular tissue of cultivating 2 months is discharged from microballoon; Carry out scanning electron microscopic observation; Fig. 6 amplifies 500 times stereoscan photograph for the three-dimensional type cardiac muscular tissue of cultivating 2 months; Fig. 7 amplifies 4000 times stereoscan photograph for the three-dimensional type cardiac muscular tissue of cultivating 2 months, can type of seeing cardiac muscular tissue have the fine and close cellularstructure of multilayer.
The three-dimensional type cardiac muscular tissue of this enforcement preparation is continued to cultivate; Observe its situation of beating; Fig. 8 for three-dimensional type of cardiac muscular tissue at the beat detection figure of frequency of different culture time synchronized; Show among the figure that type cardiac muscle cell has formed the cell-cell communication connection under three-dimensional state; Sustainable 2 months of its time of beating, the frequency dimension of beating is held in about 20～30 times.
Claims (10)
1. preparation method who is used to study the three-dimensional type cardiac muscular tissue of simulated microgravity effect; It is characterized in that being used to studying the preparation method of the three-dimensional type cardiac muscular tissue of simulated microgravity effect; Carry out according to the following steps: be 0.05%～3% sodium alginate soln with mass concentration one, be that 10%～50% type i collagen protein solution mixes, obtain mixing solutions mass concentration; Two, will the be born Wistar rat suckling mouse heart of back 1～3d places the PBS solution of 0～4 ℃ 0.1mol/L, with the PBS solution cleaning heart of 0～4 ℃ 0.1mol/L 3～5 times, again heart tissue is cut into 1～3mm then
3The tissue block of size, the PBS solution with 0～4 ℃ 0.1mol/L cleans 3～5 times again, then tissue block is digested 10～30min with Digestive system; The DMEM substratum that adds 10 times of volumes of tissue block again; Abandon supernatant after centrifugal, in deposition, add the DMEM substratum then and process cell suspension A, cell suspension A is inoculated in the culturing bottle; Adherent 90～the 120min of differential obtains the myocardial cell of purifying; Three, the myocardial cell with purifying mixes with the mixing solutions that step 1 makes, and processing cell density is 0.5 * 10
6～5 * 10
6Myocardial cell's suspension of individual/mL adopts syringe needle that myocardial cell's suspension is dropwise joined in the positive solion of divalence of 25～100mmol/L, leaves standstill 5～20min, obtains wrapping up myocardial cell's microballoon; It is after leaving standstill 5～20min in 0.1%～3% the sodium alginate soln that the microballoon that four, will wrap up the myocardial cell adds mass concentration; Put into mass concentration again and be 0.5～2% Poly-L-Lysine Solution and leave standstill 5～20min; The microballoon that will pass through the parcel myocardial cell of leaving standstill then is put in the DMEM substratum and carries out 1～2 week of dimensional culture, promptly forms the three-dimensional type cardiac muscular tissue with the function that continues to beat; Wherein the quality of type i collagen protein solution is 0.1%～50% of a sodium alginate soln quality in the step 1; Digestive system is made up of pancreatin and collagenase II in the step 2, and the mass concentration of pancreatin is 0.02～0.2% in the Digestive system, and the mass concentration of collagenase II is 0.01～0.1%; The volume of Digestive system is 9～12 times of tissue block volume in the step 2; All contain mass concentration in the DMEM substratum in step 2 and the step 4 and be 10%～15% foetal calf serum; The cell density of cell suspension A in the step 2 is 0.5 * 10
6～5 * 10
6Individual/mL; Divalent cation is calcium ion, barium ion or strontium ion in the divalent cation solution in the step 3; The volume of sodium alginate soln is 9～12 times of microsphere volume in the step 4, and the volume of Poly-L-Lysine Solution is 9～12 times of microsphere volume.
2. a kind of preparation method who is used to study the three-dimensional type cardiac muscular tissue of simulated microgravity effect according to claim 1, the mass concentration that it is characterized in that sodium alginate soln in the step 1 is 0.5%～2%.
3. a kind of preparation method who is used to study the three-dimensional type cardiac muscular tissue of simulated microgravity effect according to claim 1 and 2, the mass concentration that it is characterized in that the type i collagen protein solution is 20%～40%.
4. a kind of preparation method who is used to study the three-dimensional type cardiac muscular tissue of simulated microgravity effect according to claim 3, the quality that it is characterized in that type i collagen protein solution in the step 1 is 5%～40% of a sodium alginate soln quality.
5. a kind of preparation method who is used to study the three-dimensional type cardiac muscular tissue of simulated microgravity effect according to claim 4 is characterized in that the mass concentration of pancreatin in the Digestive system of step 2 is 0.05～0.15%.
6. a kind of preparation method who is used to study the three-dimensional type cardiac muscular tissue of simulated microgravity effect according to claim 5 is characterized in that the mass concentration of collagenase II in the Digestive system of step 2 is 0.05%.
7. a kind of preparation method who is used to study the three-dimensional type cardiac muscular tissue of simulated microgravity effect according to claim 6, it is characterized in that processing in the step 3 cell density is 1 * 10
6～3 * 10
6Myocardial cell's suspension of individual/mL.
8. a kind of preparation method who is used to study the three-dimensional type cardiac muscular tissue of simulated microgravity effect according to claim 7 is characterized in that in the step 3 myocardial cell's suspension dropwise being joined in the positive solion of divalence of 40～80mmol/L.
9. a kind of preparation method who is used to study the three-dimensional type cardiac muscular tissue of simulated microgravity effect according to claim 8, the mass concentration that it is characterized in that sodium alginate soln in the step 4 is 0.5%～2%.
10. a kind of preparation method who is used to study the three-dimensional type cardiac muscular tissue of simulated microgravity effect according to claim 9, the mass concentration that it is characterized in that Poly-L-Lysine Solution in the step 4 is 1%.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110061542 CN102174501B (en) | 2011-03-15 | 2011-03-15 | Preparation method of three-dimensional histioid cardiac muscular tissue for studying simulated microgravity effect |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110061542 CN102174501B (en) | 2011-03-15 | 2011-03-15 | Preparation method of three-dimensional histioid cardiac muscular tissue for studying simulated microgravity effect |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102174501A CN102174501A (en) | 2011-09-07 |
| CN102174501B true CN102174501B (en) | 2012-12-12 |
Family
ID=44517756
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201110061542 Expired - Fee Related CN102174501B (en) | 2011-03-15 | 2011-03-15 | Preparation method of three-dimensional histioid cardiac muscular tissue for studying simulated microgravity effect |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102174501B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109593704A (en) * | 2019-01-31 | 2019-04-09 | 北京华龛生物科技有限公司 | A kind of method of three-dimensional microcarrier cell absorption culture |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104087550B (en) * | 2014-07-10 | 2017-01-04 | 上海益诺思生物技术有限公司 | A kind of cultural method of rat myocardial cell |
| CN111621493B (en) * | 2020-06-10 | 2022-02-15 | 航天中心医院 | Cell-cleavable microcapsule, preparation method thereof and cell culture method |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1566332A (en) * | 2003-06-30 | 2005-01-19 | 中国人民解放军军事医学科学院基础医学研究所 | Method for in vitro induction of embryonic stem cell to differentiate into myocardial cell |
| CN201305602Y (en) * | 2008-10-21 | 2009-09-09 | 中国人民解放军军事医学科学院卫生装备研究所 | Bionic-type myocardial tissue bioreactor |
-
2011
- 2011-03-15 CN CN 201110061542 patent/CN102174501B/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109593704A (en) * | 2019-01-31 | 2019-04-09 | 北京华龛生物科技有限公司 | A kind of method of three-dimensional microcarrier cell absorption culture |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102174501A (en) | 2011-09-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103877622A (en) | Electrostatic spinning nanofiber-extracellular matrix composite material as well as preparation method and application thereof | |
| CN102172498B (en) | Three-dimensional porous chitosan/gelatine microsphere, preparation method thereof and application in liver cell culture | |
| CN101693126B (en) | Preparation method of poly (lactic acid-glycolic acid)/hydroxyapatite nanofiber compound bracket for bone repair | |
| CN106148270B (en) | A kind of construction method of the micro- hepatic tissue unit of three-dimensional for biological artificial liver support system | |
| CN101624473B (en) | Method for culturing hepatic cells on a large scale | |
| CN103690996A (en) | Biological compound material based on fish skin collagen and preparation method of biological compound material | |
| CN105779383A (en) | Preparation method and application of adipose-derived stem cell-hydrogel three-dimensional cultivation system | |
| CN102174501B (en) | Preparation method of three-dimensional histioid cardiac muscular tissue for studying simulated microgravity effect | |
| CN103289948B (en) | The application of a kind of GF microcarrier for cell culture in anchorage-dependent cells is cultivated | |
| CN104694466A (en) | Preparation of mesenchymal stem cells (MSCs) derived exosomes and application of the same in acute lung injury | |
| CN103275923B (en) | A kind of GF microcarrier for cell culture and preparation method thereof | |
| CN102093977A (en) | Induction factor for inducing differentiation of iPS (induced pluripotent stem) cells into cardiac muscle cells and application thereof | |
| CN108118025A (en) | A kind of foundation and its application of the three-dimensional liver model based on qualitative filter paper | |
| CN103103157A (en) | Non-contact three-dimensional co-culture method for cells | |
| CN111304168B (en) | In-vivo tumor model for three-dimensional biological printing and construction method thereof | |
| ES2778029T3 (en) | Magnetic extracellular matrix | |
| CN102329728A (en) | Chitosan/arginine-glycine-aspartic acid (RGD) three-dimensional porous microcarrier and preparation method and application thereof | |
| CN105734017A (en) | Method for promoting directional differentiation and proliferation of mesenchymal stem cells towards neural precursor cells | |
| CN101717767A (en) | Tissue engineering microencapsulated hepatocyte and preparation and application thereof | |
| Odedra et al. | Cardiac tissue engineering | |
| CN105193847A (en) | Gel preparation containing adipose-derived stem cells and preparation method and surgical dressing thereof | |
| CN107208058A (en) | Cell culture processes using marrow similar structures and the polyimide porous membrane of the treatment for bone injury site | |
| CN108084466A (en) | A kind of composite membrane that fluidized polymer is derived based on egg white and methacrylic acid and its application in terms of stem cell is cultivated | |
| CN103087533A (en) | Biological gel membrane for cell culture as well as preparation method and application thereof | |
| CN101897995B (en) | Implantable membrane-covering three-dimensional carrier and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Tian Weiming Inventor after: Zhang Jianlong Inventor after: Li Yu Inventor after: Zheng Hongxia Inventor before: Tian Weiming Inventor before: Li Yu Inventor before: Zheng Hongxia |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: TIAN WEIMING LI YU ZHENG HONGXIA TO: TIAN WEIMING ZHANG JIANLONG LI YU ZHENG HONGXIA |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121212 Termination date: 20130315 |